AI x TechBio (MMC)
MMC Ventures' AI x TechBio map (Part II) charts around 120 companies across 16 categories that apply AI to drug discovery and development, from AI co-scientists and bio AI infrastructure to virtual cells and clinical trial optimisation.
AI co-scientists
Causaly Coincidence Labs Kiin Bio Phylo DaltonTx GXL Potato Edison Scientific Science Machine
Bio AI infrastructure
Tamarind Bio Helical Salt AI
Modern labs
b12 Differential Bio Adaptyv Bio Trilobio Ganymede UniteLabs Briefly Bio Instance Lila Sciences Dash Bio OnePot AI Reactwise Medra
Drug safety
Inductive Bio Axiom Sable Bio Quris AI
Small molecules
Iambic Therapeutics Scripta Therapeutics Valo Health Terray Manas AI PostEra Genesis Therapeutics Orbis Medicines Superluminal Medicines Leash Laboratories
Protein therapeutics design
BigHat Biosciences Archon Biosciences Cradle Profluent Manifold Bio Sortera Bio Onava Nabla Bio Valink Therapeutics Latent Labs Earendil Labs
Molecular structure prediction
Isomorphic Labs Boltz Chai Discovery Topos Bio Peptone
Molecular glue
Proxima Degron Therapeutics Ternary Therapeutics Protai
RNA therapeutics, gene therapy & delivery
SymphoRNA NosisBio Mana Bio Atomic AI Cassidy Bio Aerska ExpressionEdits Brink Therapeutics Wayfinder Biosciences
Virtual cells
Noetik Tahoe Therapeutics Insitro Converge Bio CellType Turbine Relation Therapeutics QurieGen Xaira Therapeutics
Drug rescue & asset development
Ignota Labs Convexia Biosciences Pathos Formation Bio
Clinical trial optimisation
Unlearn PhaseV Delfa Biorce Sano Genetics Lindus Health Luvida
Virtual patients & clinical trials
Ingenix Bioptimus QuantHealth Theremia Vivodyne Valinor Synthesize Bio Orakl Oncology Parallel Bio Atlas Bio Karavela AI
Immunology & immune engineering
Serova Granza Bio Immunai Odyssey Therapeutics Cartography Biosciences Synteny Graph Therapeutics Immunara
Nature-derived discovery
Basecamp Research Enveda Generare Bio Outpost Bio Biomia
Physics-first approaches
Axiom Therapeutics Aqemia Achira Simulacra AI
Dealroom.co